Moderna, Biogen, Broad Institute, Harvard-affiliated labs — 46% lottery odds, cap-exempt alternatives nearby, and salary benchmarks for life sciences
Boston's biotech corridor — stretching from Kendall Square in Cambridge to the Seaport Innovation District — is one of the densest H-1B sponsorship ecosystems in the country. The region uniquely combines high-paying biotech companies filing at Level 3 (46% lottery odds) with world-class cap-exempt institutions (Harvard, MIT, Mass General, Dana-Farber) that bypass the lottery entirely. For life sciences professionals, Boston offers both the best lottery odds and the strongest backup plans.
Quick Answer: Boston biotech sponsors like Moderna, Biogen, Vertex, Sarepta, and Alnylam routinely file at Level 3 wages (46% lottery odds) for research and development roles. The Boston MSA Level 3 threshold for Life Scientists is approximately $95,000-$110,000 depending on SOC code. Plus, Harvard, MIT, Mass General, and Dana-Farber offer cap-exempt H-1B — no lottery required.
| Company | H-1B Filings | Typical Wage Level | Type |
|---|---|---|---|
| Moderna | 850 | Level 3-4 | Biotech |
| Biogen | 1,200 | Level 3-4 | Biotech |
| Vertex Pharmaceuticals | 700 | Level 3-4 | Biotech |
| Sarepta Therapeutics | 350 | Level 3 | Biotech |
| Alnylam Pharmaceuticals | 280 | Level 3 | Biotech |
| Broad Institute (MIT/Harvard) | 450 | Level 2-3 | Research (Cap-Exempt) |
| Harvard University | 2,800 | Level 1-3 | University (Cap-Exempt) |
| MIT | 1,900 | Level 1-3 | University (Cap-Exempt) |
| Mass General Brigham | 2,200 | Level 2-4 | Hospital (Cap-Exempt) |
| Dana-Farber Cancer Institute | 650 | Level 2-3 | Research (Cap-Exempt) |
Boston's H-1B landscape is uniquely advantageous because of the density of both high-paying biotech companies AND cap-exempt academic/research institutions within the same metro area. A researcher can hold a part-time cap-exempt position at Harvard or MIT while working full-time at Moderna or Biogen through concurrent employment — completely bypassing the lottery while maintaining private-sector compensation.
The biotech industry's salary structure naturally pushes many roles to Level 3 and above. Senior scientists, principal researchers, and R&D directors at companies like Moderna, Biogen, and Vertex typically earn $130,000-$200,000+ — well into Level 3 and Level 4 territory for the Boston-Cambridge-Newton MSA. Even mid-level scientists earning $95,000-$115,000 often reach Level 3 for their specific SOC code (e.g., SOC 19-1042 Medical Scientists).
The Broad Institute of MIT and Harvard occupies a special position: it is a nonprofit research organization jointly affiliated with two universities, making it cap-exempt. Its researchers work on cutting-edge genomics and computational biology, and the institution frequently facilitates transitions to biotech companies in Kendall Square — literally across the street. This proximity creates natural concurrent employment pipelines.
Find Boston-area biotech, pharma, and research sponsors with wage levels and filing history.
Search Boston Sponsors →Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →For Medical Scientists (SOC 19-1042) in the Boston-Cambridge-Newton MSA, Level 3 starts at approximately $95,000-$105,000. For Biochemists (SOC 19-1021), Level 3 starts around $100,000. For Software Developers in biotech (SOC 15-1252), Level 3 starts at approximately $140,000. Always verify exact numbers using the DOL FLAG system at flag.dol.gov — prevailing wages are updated annually.
Yes, through concurrent employment. Hold a part-time position at Harvard, MIT, or another cap-exempt institution, then have the biotech company file a concurrent H-1B petition. The concurrent petition is also exempt from the cap because you already hold H-1B status. You work for BOTH employers. Many Boston researchers use this strategy — the physical proximity of Kendall Square institutions makes it especially practical.
Yes. The Broad Institute is a nonprofit research organization affiliated with MIT and Harvard, making it cap-exempt for H-1B purposes. It can file H-1B petitions year-round without lottery participation. Positions include computational biologists, genomic researchers, data scientists, and research engineers. Salaries are competitive for academic institutions though typically lower than industry.
Several major Boston biotech companies are known for starting PERM early: Moderna (day-1 PERM standard for most roles), Vertex Pharmaceuticals (typically within first 6 months), Biogen (varies by role, usually within first year). Smaller biotechs vary widely. Ask about PERM policy during offer negotiation — with 503-day PERM backlogs, early filing is critical.